Technical Analysis for KALA - Kala Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 14.93 -3.18% -0.49
KALA closed down 3.18 percent on Friday, January 19, 2018, on 1.32 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
1 Watcher
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Up
See historical KALA trend table...

Date Alert Name Type % Chg
Jan 19 NR7 Range Contraction 0.00%
Jan 19 Wide Bands Range Expansion 0.00%
Jan 19 Down 3 Days in a Row Weakness 0.00%
Jan 18 MACD Bullish Signal Line Cross Bullish -3.18%
Jan 18 Wide Bands Range Expansion -3.18%
Jan 17 Wide Bands Range Expansion -3.68%
Jan 16 50 DMA Resistance Bearish -9.35%
Jan 16 Shooting Star Candlestick Bearish -9.35%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -9.35%
Jan 16 Wide Bands Range Expansion -9.35%

Older signals for KALA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
Is KALA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 26.75
52 Week Low 11.81
Average Volume 334,316
200-Day Moving Average 0.0
50-Day Moving Average 17.7022
20-Day Moving Average 16.201
10-Day Moving Average 14.359
Average True Range 1.5212
ADX 15.95
+DI 26.12
-DI 26.49
Chandelier Exit (Long, 3 ATRs ) 15.6064
Chandelier Exit (Short, 3 ATRs ) 16.3736
Upper Bollinger Band 20.4651
Lower Bollinger Band 11.9369
Percent B (%b) 0.35
BandWidth 52.63996
MACD Line -0.8137
MACD Signal Line -0.852
MACD Histogram 0.0383
Fundamentals Value
Market Cap 361.71 Million
Num Shares 24.2 Million
EPS -32.85
Price-to-Earnings (P/E) Ratio -0.45
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.27
Resistance 3 (R3) 16.33 15.94 16.04
Resistance 2 (R2) 15.94 15.60 15.91 15.97
Resistance 1 (R1) 15.44 15.39 15.25 15.38 15.89
Pivot Point 15.05 15.05 14.96 15.02 15.05
Support 1 (S1) 14.55 14.71 14.36 14.49 13.97
Support 2 (S2) 14.16 14.50 14.13 13.89
Support 3 (S3) 13.66 14.16 13.82
Support 4 (S4) 13.60